Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke.

Pérez-Mato M, Dopico-López A, Akkoc Y, López-Amoedo S, Correa-Paz C, Candamo-Lourido M, Iglesias-Rey R, López-Arias E, Bugallo-Casal A, da Silva-Candal A, Bravo SB, Chantada-Vázquez MDP, Arias S, Santamaría-Cadavid M, Estany-Gestal A, Zaghmi A, Gauthier MA, Gutiérrez-Fernández M, Martin A, Llop J, Rodríguez C, Almeida Á, Migliavacca M, Polo E, Pelaz B, Gozuacik D, El Yamani N, SenGupta T, Rundén-Pran E, Vivancos J, Castellanos M, Díez-Tejedor E, Sobrino T, Rabinkov A, Mirelman D, Castillo J, Campos F

Open source

DOI: 10.1016/j.isci.2024.111108
Published: 2024 Nov 15
Container: iScience
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2024.111108,
  title = {Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke.},
  author = {Pérez-Mato M and Dopico-López A and Akkoc Y and López-Amoedo S and Correa-Paz C and Candamo-Lourido M and Iglesias-Rey R and López-Arias E and Bugallo-Casal A and da Silva-Candal A and Bravo SB and Chantada-Vázquez MDP and Arias S and Santamaría-Cadavid M and Estany-Gestal A and Zaghmi A and Gauthier MA and Gutiérrez-Fernández M and Martin A and Llop J and Rodríguez C and Almeida Á and Migliavacca M and Polo E and Pelaz B and Gozuacik D and El Yamani N and SenGupta T and Rundén-Pran E and Vivancos J and Castellanos M and Díez-Tejedor E and Sobrino T and Rabinkov A and Mirelman D and Castillo J and Campos F},
  year = {2024},
  journal = {iScience},
  doi = {10.1016/j.isci.2024.111108},
  url = {https://doi.org/10.1016/j.isci.2024.111108}
}

RIS

TY  - JOUR
TI  - Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke.
AU  - Pérez-Mato M
AU  - Dopico-López A
AU  - Akkoc Y
AU  - López-Amoedo S
AU  - Correa-Paz C
AU  - Candamo-Lourido M
AU  - Iglesias-Rey R
AU  - López-Arias E
AU  - Bugallo-Casal A
AU  - da Silva-Candal A
AU  - Bravo SB
AU  - Chantada-Vázquez MDP
AU  - Arias S
AU  - Santamaría-Cadavid M
AU  - Estany-Gestal A
AU  - Zaghmi A
AU  - Gauthier MA
AU  - Gutiérrez-Fernández M
AU  - Martin A
AU  - Llop J
AU  - Rodríguez C
AU  - Almeida Á
AU  - Migliavacca M
AU  - Polo E
AU  - Pelaz B
AU  - Gozuacik D
AU  - El Yamani N
AU  - SenGupta T
AU  - Rundén-Pran E
AU  - Vivancos J
AU  - Castellanos M
AU  - Díez-Tejedor E
AU  - Sobrino T
AU  - Rabinkov A
AU  - Mirelman D
AU  - Castillo J
AU  - Campos F
PY  - 2024
JO  - iScience
DO  - 10.1016/j.isci.2024.111108
UR  - https://doi.org/10.1016/j.isci.2024.111108
ER  -

APA

M, P., A, D., Y, A., S, L., C, C., M, C., R, I., E, L., A, B., A, D. S., SB, B., MDP, C., S, A., M, S., A, E., A, Z., MA, G., M, G., A, M., J, L., C, R., Á, A., M, M., E, P., B, P., D, G., N, E. Y., T, S., E, R., J, V., M, C., E, D., T, S., A, R., D, M., J, C., & F, C. (2024). Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke.. iScience. https://doi.org/10.1016/j.isci.2024.111108

Source records

pubmed · retrieved 2026-09-26T07:54:46.713Z